You just read:

TapImmune Announces Finalization of License Agreement With Mayo Clinic To Commercialize a Folate Receptor Alpha Vaccine for Multiple Cancer Indications

News provided by

TapImmune, Inc.

Jul 27, 2015, 08:30 ET